LEADER 01990nam  2200397z- 450 
001 9910261137803321
005 20231214133137.0
035   $a(CKB)4100000002484714
035   $a(oapen)https://directory.doabooks.org/handle/20.500.12854/53854
035   $a(EXLCZ)994100000002484714
100   $a20202102d2017      |y             0
101 0 $aeng
135   $aurmn|---annan
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aMolecular Pathogenesis of Pneumococcus
210   $cFrontiers Media SA$d2017
215   $a1 electronic resource (110 p.)
225 1 $aFrontiers Research Topics
311   $a2-88945-278-6 
330   $aStreptococcus pneumoniae has been for decades the number one bacterial killer of children in the world. Although vaccination with pneumococcal vaccines [PCV7, PCV10, and PCV13 (children) or PPSV23 (adults)] has helped decrease the burden of pneumococcal disease (PD), mortality remains high. Therefore, pathogenesis studies are still key toward our understanding of PD and its control. The introduction of pneumococcal vaccines has also created a niche for vaccine-escape clones. Moreover, the rise of multi-drug resistant clones around the world has also posed a serious threat in recent years. The proposed special issue of Frontiers in Cellular and Infection Microbiology highlights many of the recent advances that have been made in pneumococcal pathogenesis, colonization and antibiotic resistance by groups in Latino America, Europe, and the USA.
610   $apathogenesis
610   $amacrophages
610   $aco-infection
610   $agene regulation
610   $abiofilm
610   $adrug resistance
610   $amicrobial
610   $aStreptococcus pneumoniae
700   $aGuangchun Bai$4auth$01306121
702   $aJorge Eugenio Vidal$4auth
906   $aBOOK
912   $a9910261137803321
996   $aMolecular Pathogenesis of Pneumococcus$93028286
997   $aUNINA